XML 15 R23.htm IDEA: XBRL DOCUMENT

Segment Information (Tables)

3 Months Ended

Sep. 30, 2011

Segment Reporting [Abstract]

Segment Information [Text Block]


	Three Months Ended September 30,		Nine Months Ended September 30,
	2011	2010	2011	2010
	(Dollars in millions)
Revenue– to unaffiliated customers:
Neuroscience	$2,488.0	$2,246.4	$ 7,547.1	$ 6,854.2
Endocrinology	1,692.9	1,510.4	4,965.4	4,506.9
Oncology	817.8	980.3	2,483.5	2,837.1
Cardiovascular	630.1	517.6	1,852.5	1,569.3
Animal health	451.0	353.3	1,210.4	967.1
Other pharmaceuticals	68.1	46.8	181.0	154.4
Total revenue	$6,147.9	$5,654.8	$18,239.9	$16,889.0

Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.

+ References+ Details